Page last updated: 2024-08-21

hematoxylin and Myeloproliferative Disorders

hematoxylin has been researched along with Myeloproliferative Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Atamanyuk, V; Balligand, T; Constantinescu, SN; Jia, R; Kralovics, R; Kubicek, S; Kutzner, L; Lesyk, R; Nedelec, A; Nivarthi, H; Weinzierl, J; Xu, E; Zagrijtschuk, O	1

Other Studies

1 other study(ies) available for hematoxylin and Myeloproliferative Disorders

Article	Year
Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptor. Blood, 2021, 04-08, Volume: 137, Issue:14 Topics: Animals; Binding Sites; Calreticulin; Cell Line; Drug Discovery; Hematoxylin; Humans; Mice; Molecular Docking Simulation; Mutagenesis, Site-Directed; Mutation; Myeloproliferative Disorders; Protein Binding; Protein Interaction Maps; Receptors, Thrombopoietin	2021

Article

Year

Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptor.

Blood, 2021, 04-08, Volume: 137, Issue:14

Topics: Animals; Binding Sites; Calreticulin; Cell Line; Drug Discovery; Hematoxylin; Humans; Mice; Molecular Docking Simulation; Mutagenesis, Site-Directed; Mutation; Myeloproliferative Disorders; Protein Binding; Protein Interaction Maps; Receptors, Thrombopoietin

2021